Coral Laboratories [CORALAB] vs Sun Pharma Advanced [SPARC] Detailed Stock Comparison

Coral Laboratories Ltd.

BSE
Loading...

Sun Pharma Advanced Research Company Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Coral Laboratories Ltd. wins in 14 metrics, Sun Pharma Advanced Research Company Ltd. wins in 4 metrics, with 0 ties. Coral Laboratories Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Coral Laboratories Ltd. Sun Pharma Advanced Research Company Ltd. Better
P/E Ratio (TTM) 11.06 -13.65 Coral Laboratories Ltd.
Price-to-Book Ratio 0.73 -13.55 Coral Laboratories Ltd.
Debt-to-Equity Ratio 0.41 -1.21 Coral Laboratories Ltd.
PEG Ratio -0.20 -11.15 Coral Laboratories Ltd.
EV/EBITDA 4.44 -22.27 Coral Laboratories Ltd.
Profit Margin (TTM) 15.97% -53.22% Coral Laboratories Ltd.
Operating Margin (TTM) 5.58% -700.71% Coral Laboratories Ltd.
EBITDA Margin (TTM) 5.58% N/A N/A
Return on Equity 12.01% 157.88% Sun Pharma Advanced Research Company Ltd.
Return on Assets (TTM) 10.53% -102.08% Coral Laboratories Ltd.
Free Cash Flow (TTM) $-41.67M $-3.71B Coral Laboratories Ltd.
Dividend Yield 0.29% N/A N/A
1-Year Return -18.38% 34.88% Sun Pharma Advanced Research Company Ltd.
Price-to-Sales Ratio (TTM) 1.77 87.98 Coral Laboratories Ltd.
Enterprise Value $532.28M $50.87B Sun Pharma Advanced Research Company Ltd.
EV/Revenue Ratio 0.61 95.73 Coral Laboratories Ltd.
Gross Profit Margin (TTM) 59.74% -59.53% Coral Laboratories Ltd.
Revenue per Share (TTM) $245 $2 Coral Laboratories Ltd.
Earnings per Share (Diluted) $39.14 $-8.25 Coral Laboratories Ltd.
Beta (Stock Volatility) 0.90 0.19 Sun Pharma Advanced Research Company Ltd.

Coral Laboratories Ltd. vs Sun Pharma Advanced Research Company Ltd. Stock Performance Analysis

Loading Price Chart...

CORALAB
SPARC

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Coral Laboratories Ltd.2.22%0.75%9.98%18.09%9.54%13.35%
Sun Pharma Advanced Research Company Ltd.2.36%12.49%39.95%100.62%67.89%69.61%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Coral Laboratories Ltd.-18.38%101.77%4.69%9.89%526.74%564.59%
Sun Pharma Advanced Research Company Ltd.34.88%14.54%-3.55%-20.47%148.26%-23.02%

Performance & Financial Health Analysis: Coral Laboratories Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricCORALABSPARC
Market Information
Market Cap i₹1.53B₹46.75B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i1,5662,401,062
90 Day Avg. Volume i2,8152,083,443
Last Close₹500.65₹229.03
52 Week Range₹360.00 - ₹624.95₹108.00 - ₹248.75
% from 52W High-19.89%-7.93%
All-Time High₹1,190.00 (Jul 24, 2017)₹875.00 (Apr 24, 2006)
% from All-Time High-57.93%-73.83%
Growth Metrics
Quarterly Revenue Growth-0.06%-0.43%
Quarterly Earnings Growth-0.55%-0.43%
Financial Health
Profit Margin (TTM) i0.16%-0.53%
Operating Margin (TTM) i0.06%-7.01%
Return on Equity (TTM) i0.12%1.58%
Debt to Equity (MRQ) i0.41-1.21
Cash & Liquidity
Book Value per Share (MRQ)₹596.42₹-10.63
Cash per Share (MRQ)₹286.45₹0.03
Operating Cash Flow (TTM) i₹106.44M₹-3,484,287,000
Levered Free Cash Flow (TTM) i₹241.56M₹-3,425,094,000
Dividends
Last 12-Month Dividend Yield i0.29%N/A
Last 12-Month Dividend i₹1.50N/A

Valuation & Enterprise Metrics Analysis: Coral Laboratories Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricCORALAB (Apr 24, 2026)SPARC (Apr 22, 2026)
Price Ratios
P/E Ratio (TTM) i11.06-13.65
Forward P/E i7.452.60
PEG Ratio i-0.20-11.15
Price to Sales (TTM) i1.7787.98
Price to Book (MRQ) i0.73-13.55
Market Capitalization
Market Capitalization i₹1.53B₹46.75B
Enterprise Value i₹532.28M₹50.87B
Enterprise Value Metrics
Enterprise to Revenue i0.6195.73
Enterprise to EBITDA i4.44-22.27
Risk & Other Metrics
Beta i0.900.19
Book Value per Share (MRQ) i₹596.42₹-10.63

Financial Statements Comparison: Coral Laboratories Ltd. vs Sun Pharma Advanced Research Company Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricCORALAB (2025)SPARC (2025)
Revenue/Sales i1.13B717.66M
Cost of Goods Sold i561.92M1.10B
COGS % of Revenue i49.6%153.2%
Gross Profit i569.87M-381.94M
Gross Margin i50.4%-53.2%
Research & Development iN/AN/A
Operating Income (EBIT) i246.11M-3.34B
Operating Margin i21.7%-465.5%
EBITDA i353.48M-3.23B
EBITDA Margin i31.2%-450.0%
Pre-Tax Income i324.70M-3.43B
Pre-Tax Income % of Revenue i28.7%-477.6%
Income Tax i83.15M-2.72M
Income Tax % of Revenue i7.3%-0.4%
Net Income (Profit) i241.56M-3.43B
Profit Margin i21.3%-477.3%

Balance Sheet & Liquidity Metrics

MetricCORALAB (2025)SPARC (2025)
Cash & Equivalents i34.06M19.64M
Total Current Assets i1.77B261.97M
Total Current Assets % of Revenue i156.0%36.5%
Total Current Liabilities i249.58M3.74B
Total Current Liabilities % of Revenue i22.1%521.5%
Long-Term Debt i01.07B
Long-Term Debt % of Revenue i0.0%149.0%
Total Shareholders Equity i2.01B-2.17B
Retained Earnings i1.71B-23.22B
Retained Earnings % of Revenue i151.0%-3,235.0%
Property, Plant & Equipment i217.44M178.02M

Cash Flow Statement Comparison

MetricCORALAB (2025)SPARC (2025)
Operating Cash Flow i106.44M-3.48B
Operating Cash Flow % of Revenue i9.4%-485.5%
Capital Expenditures i-29.45M-97.45M
Free Cash Flow i-41.67M-3.71B
FCF Margin i-3.7%-516.4%
Debt Repayment iN/A-3.69B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricCORALABSPARC
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i3.57M324.52M
Float Shares i802,60991.32M
% Held by Insiders i78.86%72.96%
% Held by Institutions i0.00%2.56%
% Held by Public i21.14%24.48%

Dividend Analysis & Yield Comparison: Coral Laboratories Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricCORALABSPARC
Last 12-Month Dividend i₹1.50N/A
Last 12-Month Dividend Yield i0.29%N/A
3-Year Avg Annual Dividend i₹1.17N/A
3-Year Avg Dividend Yield i0.26%N/A
3-Year Total Dividends i₹3.50N/A
Ex-Dividend DateSep 19, 2025N/A